Zolmitriptan Tablet, Film Coated
Product Images NDC 46708-463

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 46708-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6 Tablets In 1 Carton (Zolmitriptan 25mg)

Packaging label for Zolmitriptan Tablets, USP 2.5 mg oral film-coated tablets by Alembic Pharmaceuticals Limited. The box contains 6 unit-dose tablets (1 x 6). The front and sides of the carton prominently display the strength as 2.5 mg along with the NDC 46708-462-06 and the Alembic logo.*

FDA Label Image

3 Tablets In 1 Carton (Zolmitriptan 5mg)

Packaging label for Zolmitriptan Tablets, USP, 5 mg oral film-coated tablets. The package contains 3 unit-dose tablets. Labeled as Rx only and manufactured by Alembic Pharmaceuticals Limited. The label includes the NDC code 46708-463-03 and displays dosage strength prominently multiple times on a white background with blue accents.*

FDA Label Image

Figure 1 (Zolmitriptan Figure1)

A line graph showing the estimated probability of response over time from initial dose (0 to 4 hours) for placebo and zolmitriptan at 1 mg, 2.5 mg, and 5 mg doses. The graph compares the probability percentages from 0% to 100%, illustrating higher response probabilities for zolmitriptan doses compared to placebo over the 4-hour period.*

FDA Label Image

Figure 2 (Zolmitriptan Figure2)

A line graph depicting the estimated probability of medication or rescue over 24 hours from the initial dose for Zolmitriptan. The graph compares placebo and three dose levels (1 mg, 2.5 mg, and 5 mg), showing their respective response probabilities over time.*

FDA Label Image

Structure (Zolmitriptan Str)

Chemical structure of Zolmitriptan, showing its molecular framework including a fused bicyclic system and a dimethylaminoethyl side chain. The structure highlights key functional groups identifiable for Zolmitriptan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.